Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Selective MRP1-mediated multidrug resistant modulator characterized by Vertex

July 24, 2003

Austrianova's cell therapy receives European orphan drug status

July 23, 2003

MediciNova studying potential of SOCC-specific inhibitors for cancer

July 23, 2003

SkyePharma licenses European Depocyte rights to Mundipharma

July 23, 2003

Antitumor activity of the novel coxib CS-706 (R-109339) in mice

July 23, 2003

U. of Oklahoma researchers identify novel proapoptotic antitumor compounds

July 23, 2003

Small-molecule inhibitor of IGF-IR kinase activity characterized at cancer meeting

July 22, 2003

CanBas identifies peptide with the ability to abrogate the G2 cell cycle checkpoint

July 22, 2003

Small-molecule Bcl-xL/Bcl-2 antagonist with potential for combination therapy

July 22, 2003

AACR news: agonist antibodies to TRAIL-R2 show promise for the treatment of cancer

July 22, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...